Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 426,000 | 570,000 | 928,000 | 338,000 | 276,000 |
| Receivables | 2,134,000 | 2,076,000 | 1,970,000 | 1,871,000 | 1,917,000 |
| Inventories | 2,250,000 | 2,050,000 | 1,867,000 | 1,788,000 | 1,752,000 |
| Other current assets | 773,000 | 712,000 | 731,000 | 885,000 | 874,000 |
| TOTAL | $5,886,000 | $5,704,000 | $5,760,000 | $5,144,000 | $5,083,000 |
| Non-Current Assets | |||||
| PPE Net | 2,534,000 | 2,478,000 | 2,446,000 | 2,273,000 | 2,246,000 |
| Intangibles | 19,722,000 | 19,329,000 | 18,822,000 | 18,910,000 | 19,232,000 |
| Other Non-Current Assets | 5,460,000 | 5,382,000 | 5,442,000 | 5,620,000 | 5,628,000 |
| TOTAL | $27,716,000 | $27,189,000 | $26,710,000 | $26,803,000 | $27,106,000 |
| Total Assets | $33,601,000 | $32,892,000 | $32,469,000 | $31,947,000 | $32,189,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 559,000 | 510,000 | 20,000 | 20,000 | 170,000 |
| Accounts payable and accrued liabilities | 899,000 | 868,000 | 862,000 | 803,000 | 732,000 |
| Accrued Expenses | 2,164,000 | 1,918,000 | 2,160,000 | 1,974,000 | 2,197,000 |
| Other current liabilities | 940,000 | 787,000 | 761,000 | 752,000 | 784,000 |
| TOTAL | $4,562,000 | $4,083,000 | $3,803,000 | $3,549,000 | $3,883,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,494,000 | 8,495,000 | 8,915,000 | 8,564,000 | 8,802,000 |
| Other Non-Current Liabilities | 1,926,000 | 1,995,000 | 2,035,000 | 1,916,000 | 1,988,000 |
| TOTAL | $10,555,000 | $10,700,000 | $11,094,000 | $10,758,000 | $11,055,000 |
| Total Liabilities | $15,116,000 | $14,783,000 | $14,896,000 | $14,307,000 | $14,938,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,464,223 | 1,437,698 | 1,434,780 | 1,432,311 | 1,431,614 |
| Common Shares | 17,000 | 17,000 | 17,000 | 17,000 | 17,000 |
| Retained earnings | -189,000 | -450,000 | -750,000 | -876,000 | -1,050,000 |
| Other shareholders' equity | 467,000 | 437,000 | 268,000 | 531,000 | 432,000 |
| TOTAL | $18,485,000 | $18,109,000 | $17,573,000 | $17,640,000 | $17,251,000 |
| Total Liabilities And Equity | $33,601,000 | $32,892,000 | $32,469,000 | $31,947,000 | $32,189,000 |